These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3542288)

  • 1. Screening for cerebrotendinous xanthomatosis by using an enzymatic assay for 7 alpha-hydroxylated steroids in urine.
    Koopman BJ; Van der Molen JC; Wolthers BG; Waterreus RJ
    Clin Chem; 1987 Jan; 33(1):142-3. PubMed ID: 3542288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary gas chromatography of urine samples in diagnosing cerebrotendinous xanthomatosis.
    Bouwes Bavinck JN; Vermeer BJ; Gevers Leuven JA; Koopman BJ; Wolthers BG
    Arch Dermatol; 1986 Nov; 122(11):1269-72. PubMed ID: 3777973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Capillary gas chromatographic determinations of urinary bile acids and bile alcohols in CTX patients proving the ineffectivity of ursodeoxycholic acid treatment.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Waterreus RJ; Oosterhuis HJ
    Clin Chim Acta; 1984 Sep; 142(1):103-11. PubMed ID: 6478619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrotendinous xanthomatosis: a review of biochemical findings of the patient population in The Netherlands.
    Koopman BJ; Wolthers BG; van der Molen JC; van der Slik W; Waterreus RJ; van Spreeken A
    J Inherit Metab Dis; 1988; 11(1):56-75. PubMed ID: 3128689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bile alcohol profiles in bile, urine, and feces of a patient with cerebrotendinous xanthomatosis.
    Shimazu K; Kuwabara M; Yoshii M; Kihira K; Takeuchi H; Nakano I; Ozawa S; Onuki M; Hatta Y; Hoshita T
    J Biochem; 1986 Feb; 99(2):477-83. PubMed ID: 3700361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of (23S)-5 alpha-cholestane-3 alpha,7 alpha,12 alpha,23,25-pentol in urine of patients with cerebrotendinous xanthomatosis.
    Kihira K; Fukuda K; Kuramoto T; Kuriyama M; Fujiyama J; Osame M; Hoshita T
    Steroids; 1991 Sep; 56(9):464-8. PubMed ID: 1805458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of short side chain bile acids in urine of patients with cerebrotendinous xanthomatosis.
    Kuramoto T; Furukawa Y; Nishina T; Sugimoto T; Mahara R; Tohma M; Kihira K; Hoshita T
    J Lipid Res; 1990 Oct; 31(10):1895-902. PubMed ID: 2079611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis of cerebrotendinous xanthomatosis (CTX) and effect of chenodeoxycholic acid therapy by analysis of urine using capillary gas chromatography.
    Wolthers BG; Volmer M; van der Molen J; Koopman BJ; de Jager AE; Waterreus RJ
    Clin Chim Acta; 1983 Jun; 131(1-2):53-65. PubMed ID: 6883710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased (23R)-hydroxylase activity in patients suffering from cerebrotendinous xanthomatosis, resulting in (23R)-hydroxylation of bile acids.
    Koopman BJ; Wolthers BG; Van der Molen JC; Nagel GT; Rutgers H; Strijtveen B; Kaptein B
    Biochim Biophys Acta; 1986 Oct; 883(3):585-92. PubMed ID: 3756224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel pathway for biosynthesis of cholestanol with 7 alpha-hydroxylated C27-steroids as intermediates, and its importance for the accumulation of cholestanol in cerebrotendinous xanthomatosis.
    Skrede S; Björkhem I; Buchmann MS; Hopen G; Fausa O
    J Clin Invest; 1985 Feb; 75(2):448-55. PubMed ID: 3919058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrotendinous xanthomatosis.
    Hwang SY; Lee KH; Ahn JI
    J Dermatol; 1990 Feb; 17(2):115-9. PubMed ID: 2329221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of carriers of cerebrotendinous xanthomatosis.
    Koopman BJ; Waterreus RJ; Van den Brekel HW; Wolthers BG
    Clin Chim Acta; 1986 Jul; 158(2):179-85. PubMed ID: 3742821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Configuration at C-25 in 5 beta-cholestane-3 alpha,7 alpha,12 alpha,25,26-pentol excreted by patients with cerebrotendinous xanthomatosis: circular dichroism and 13C-NMR studies.
    Dayal B; Salen G; Toome V; Tint GS
    J Lipid Res; 1986 Dec; 27(12):1328-32. PubMed ID: 3559396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assay of intermediates in bile acid biosynthesis using isotope dilution--mass spectrometry: hepatic levels in the normal state and in cerebrotendinous xanthomatosis.
    Björkhem I; Oftebro H; Skrede S; Pedersen JI
    J Lipid Res; 1981 Feb; 22(2):191-200. PubMed ID: 7017048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G; Shefer S; Tint GS
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormal urinary bile acids in a patient suffering from cerebrotendinous xanthomatosis during oral administration of ursodeoxycholic acid.
    Koopman BJ; Wolthers BG; van der Molen JC; Nagel GT; Kruizinga W
    Biochim Biophys Acta; 1987 Feb; 917(2):238-46. PubMed ID: 3801500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric disorders in patients with cerebrotendinous xanthomatosis.
    Berginer VM; Foster NL; Sadowsky M; Townsend JA; Siegel GJ; Salen G
    Am J Psychiatry; 1988 Mar; 145(3):354-7. PubMed ID: 3344851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Juvenile cataract associated with chronic diarrhea in pediatric cerebrotendinous xanthomatosis.
    Cruysberg JR; Wevers RA; Tolboom JJ
    Am J Ophthalmol; 1991 Nov; 112(5):606-7. PubMed ID: 1951610
    [No Abstract]   [Full Text] [Related]  

  • 19. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
    Dayal B; Tint GS; Greeley DN; Williams TH; Salen G
    Steroids; 1983 Oct; 42(4):441-8. PubMed ID: 6679948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
    Setoguchi T; Salen G; Tint GS; Mosbach EH
    J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.